


David Nicklaus
David Nicklaus is a business columnist for the St. Louis Post-Dispatch.
Get email notifications on {{subject}} daily!
{{description}}
Email notifications are only sent once a day, and only if there are new matching items.
Followed notifications
Please log in to use this feature
Log InScottrade founder Rodger Riney and his wife, Paula, are donating $7.5 million to BioSTL to support the group's work creating early-stage biotech companies.
-
Nicklaus: Stay out of politics? Companies decide they can't afford to
-
Nicklaus: Short-selling sharks circle Amdocs for a second time
-
Nicklaus: Our pandemic-era Zoom habits might boost productivity, but it’s too early to count on gains
-
COVID-19 hits RGA executives' bonuses and stock awards
-
Stifel CEO earns $10.7 million as earnings rise
Riney sold Scottrade to TD Ameritrade in 2017 for $4 billion. Since then, he has invested in startups including Arch Oncology and Geneoscopy. He also donated more than $200 million to charity.
The BioSTL gift comes from the Paula and Rodger Riney Charitable Fund, which is managed by the St. Louis Community Foundation. BioSTL President Donn Rubin said the gift "will help propel the pace of discovery and new company creation" in St. Louis.
BioSTL has invested in 81 early-stage companies through BioGenerator, its investment arm. It also provides lab space to startups and has trained 337 women and minority entrepreneurs through its Entrepreneur Inclusion Initiative.
Want to stay smart about what's happening in St. Louis? Make a modest investment in a Post-Dispatch subscription and I'll tell you how developments around the world affect local businesses big and small.
Daily updates on the latest news in the St. Louis business community.
David Nicklaus
David Nicklaus is a business columnist for the St. Louis Post-Dispatch.
Get email notifications on {{subject}} daily!
{{description}}
Email notifications are only sent once a day, and only if there are new matching items.